Susquehanna Raises Price Target on Immucor (BLUD) to $35
More News related to BLUD
- Matrix USA Rating Changes 10/9
- Immucor (BLUD) Tops Q1 Earnings Views; Guides FY09
- Trading Radar for 10/1: Mosaic (MOS), Micron (MU), Actuant (ATU) Report; Auto/Truck Sales, ADP Employment Report, Construction Spending, Crude Inventories Due
- Immucor (BLUD) Announces Change in Board Members
- Susquehanna Raises Price Target on Immucor (BLUD) to $35
More News related to Analyst Comments
- After-Hours Movers 12/05: Actuate (ACTU) Up On Higher Tender Offer, RF Micro (RFMD) Lower on Guidance
- Trading Radar for 12/05: Big Lots (BIG), Flow Int'l (FLOW), Blyth (BTH) Report; Nonfarm Payrolls, Unemployment Rate, Consumer Credit Due
- Unusual 11 Mid-Day Movers 12/04: DXCM, TLB, PRKR, PSS Higher; CRUS, DMND, ITWO, DDMX Lower
- Notable Analyst Rating Changes 12/04: AMZN, YRCW, GPN, TRI Upgraded; DMND, DOX, FMCN, ISIL Downgraded
- Morning Movers 12/04: Merck (MRK) Lower On Guidance, Amazon.com (AMZN) Higher On Upgrade
Susquehanna raises its price target on Immucor (Nasdaq: BLUD) from $31 to $35. The firm maintains a Positive rating on the stock.
The firm said that yesterday's Q4 results, reported yesterday, prove that Immucor's management has once again executed on its "objective to drive blood bank automation.." Susquehanna believes Immucor "will drive double-digit top-line growth through steady, consistent price increases on Traditional reagents, continued automation conversion and share gains with its two leading technology systems."
Immucor, Inc., together with its subsidiaries, develops, manufactures, and sells a range of reagents and automated systems.
Related Categories
Analyst CommentsStocks Mentioned
-0.88Related Entities
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
